MGC Pharmaceuticals Ltd
ASX:MXC

Watchlist Manager
MGC Pharmaceuticals Ltd Logo
MGC Pharmaceuticals Ltd
ASX:MXC
Watchlist
Price: 0.415 AUD
Market Cap: 18.2m AUD

MGC Pharmaceuticals Ltd
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

MGC Pharmaceuticals Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
MGC Pharmaceuticals Ltd
ASX:MXC
Free Cash Flow
-AU$932.8k
CAGR 3-Years
58%
CAGR 5-Years
31%
CAGR 10-Years
6%
Mayne Pharma Group Ltd
ASX:MYX
Free Cash Flow
-AU$11.5m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Free Cash Flow
AU$137.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Free Cash Flow
-AU$79.6m
CAGR 3-Years
-78%
CAGR 5-Years
-35%
CAGR 10-Years
-52%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Free Cash Flow
-AU$55m
CAGR 3-Years
-60%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Nyrada Inc
ASX:NYR
Free Cash Flow
-AU$5.1m
CAGR 3-Years
-20%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

MGC Pharmaceuticals Ltd
Glance View

Market Cap
18.2m AUD
Industry
Pharmaceuticals

MGC Pharmaceuticals Ltd. engages in the production of medical marijuana. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-12-21. The firm is primarily focused on producing standardized, phytocannabinoid and plant-derived medicines. The Company’s Nature to Medicine strategy comprises the entire supply chain, from botanical research, to develop new strains of Cannabis Sativa, preclinical and clinical research, product manufacturing, distribution, as well as the development of drug delivery systems. The Group has also completed a Phase II double-blind, randomized, placebo controlled clinical trial in Israel and India, to evaluate the safety and efficacy of a natural anti-inflammatory based formulation ArtemiC on patients diagnosed with Corona Virus Disease 2019 (COVID-19).

MXC Intrinsic Value
Not Available

See Also

What is MGC Pharmaceuticals Ltd's Free Cash Flow?
Free Cash Flow
-932.8k AUD

Based on the financial report for Dec 31, 2023, MGC Pharmaceuticals Ltd's Free Cash Flow amounts to -932.8k AUD.

What is MGC Pharmaceuticals Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
6%

Over the last year, the Free Cash Flow growth was 93%. The average annual Free Cash Flow growth rates for MGC Pharmaceuticals Ltd have been 58% over the past three years , 31% over the past five years , and 6% over the past ten years .

Back to Top